Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: Absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts

Journal of Acquired Immune Deficiency Syndromes

Volumn 25, Issue 3, 2000, Pages 261-268

  Bulterys, Marc ^a   Burchett, Sandra K ^b   Culnane, Mary ^c   Cunningham Schrader, Bethann ^d   Dominguez, Ken ^e   Dunkle, Lisa ^f   Draper, Linda ^d   Fowler, Mary Glenn ^e   Hanson, Celine ^g   Kpamegan, Eloi ^h   Lindegren, Mary Lou ^e   Martin Carpenter, Louise ⁱ   McIntosh, Kenneth ^b   McNamara, James ^c   McSherry, George ^j   Mitchell, Wendy G ^k   Mofenson, Lynne M ^l   Oleske, James M ^j   Rhodes, Phillip ^e   Shapiro, David E ^m   Smith, Mary E ^c   Styrt, Barbara ⁿ   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h Clinical Trials & Surveys Corp   (United States)

ⁱ GLAXOSMITHKLINE   (United States)

^j RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^m CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

ⁿ CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

more..

Author keywords

Antiretroviral drugs; HIV; Infants; Mitochondrial dysfunction; Mothers

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; PLACEBO; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; AUTOPSY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FATALITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTICENTER STUDY; PERINATAL DRUG EXPOSURE; PLACENTAL TRANSFER; PRESCHOOL CHILD; PRIORITY JOURNAL; RATING SCALE; SUDDEN INFANT DEATH SYNDROME;

EID: 0034319154     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200011010-00009     Document Type: Article

References (37)

1. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States
2. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
3. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment
4. The safety and efficacy of protease inhibitor therapy for HIV infection during pregnancy
5. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity
6. Mitochondrial toxicity of antiviral drugs
7. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
8. Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment
9. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model
10. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria
11. Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3′-azido-3′-deoxythymidine
12. Mitochondrial myopathy caused by long-term zidovudine therapy
13. Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine
14. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams
15. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
16. The Women and Infants Transmission Study (WITS) of mother-infant HIV transmission: Study design, methods, and baseline data
17. Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. Perinatal AIDS Collaborative Transmission Studies
18. Prevalence of HIV infection in the United States, 1984 to 1992
19. Natural history of human immunodeficiency virus disease in perinatally infected children: An analysis from the Pediatric Spectrum of Disease Project
20. Trends in perinatal transmission of HIV/AIDS in the United States
21. Impact of the human immunodeficiency virus epidemic on mortality in children, United States
22. Guidelines for the use of antiretroviral agents in pediatric HIV infection
23. Guidelines for National Human Immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome
24. Mitochondrial diseases
25. Mitochondrial diseases: Clinical considerations
26. Clinical presentation of mitochondrial disorders in childhood
27. Fatal hepatic short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: Clinical, biochemical, and pathological studies on three subjects with this recently identified disorder of mitochondrial beta-oxidation
28. Enzyme deficit may cause SIDS
29. Sudden infant death syndrome - United States, 1980-1988
30. Epidemiology of the sudden infant death syndrome: Maternal, neonatal, and postneonatal risk factors
31. Sudden infant death syndrome in Washington State: Why are Native American infants at greater risk than white infants?
32. Epidemiology of SIDS and explained sudden infant deaths. CESDI SUDI Research Group
33. United States abridged life tables, 1996
34. HIV nucleoside analogues: New adverse effects on mitochondria?